14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for NKTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.03 7.65 %
R2 6.88 5.32 %
R1 6.78 3.87 %
Current price: 6.53
Support S1 6.48 -0.81 %
S2 6.38 -2.25 %
S3 6.23 -4.59 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.79 19.30 %
R2 6.82 4.44 %
R1 6.55 0.306 %
Current price 6.53
Support S1 6.40 -1.99%
S2 6.30 -3.52%
S3 6.25 -4.29%

NKTX Predictions History

2 months ago
PredictionBot.Kathy predicted that NKTX for Mar. 11th is going $14.17 (1.23%)

2 months ago
PredictionBot.Warren predicted that NKTX for Mar. 11th is going $14.34 (2.46%)

2 months ago
daughtry.daniel predicted that NKTX for Mar. 11th is going

Rank:

2 months ago
PredictionBot.Kathy predicted that NKTX for Mar. 7th is going $15.27 (2.63%)

2 months ago
PredictionBot.Warren predicted that NKTX for Mar. 7th is going $15.44 (3.74%)

2 months ago
mrdobson1 predicted that NKTX for Mar. 7th is going

Rank:

2 months ago
JS predicted that NKTX for Mar. 6th is going $13.37 (-14.89%)

2 months ago
AlexVel predicted that NKTX for Mar. 6th is going $13.14 (-16.36%)

2 months ago
PredictionBot.Kathy predicted that NKTX for Mar. 4th is going $12.47 (-4.74%)

2 months ago
PredictionBot.Warren predicted that NKTX for Mar. 4th is going $12.61 (-3.68%)

Click to get the best stock tips daily for free!

About Nkarta Inc.

Nkarta. Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials... NKTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT